Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Thorne HealthTech, Inc. THRN NASDAQ

NASDAQ Global Select • Consumer Defensive • Packaged Foods • US • USD

SharesGrow Score
60/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.75
-43.6%

Thorne HealthTech, Inc. (THRN) is a Packaged Foods company in the Consumer Defensive sector, currently trading at $10.19. It has a SharesGrow Score of 60/100, indicating a above average investment profile with 2 out of 7 criteria passed.

Analyst consensus target is THRN = $6 (-43.6% upside).

Financials: revenue is $229M, +30.8%/yr average growth. Net income is $16M, growing at +221.5%/yr. Net profit margin is 6.9% (thin). Gross margin is 50.2% (+6.6 pp trend).

Balance sheet: total debt is $47M against $145M equity (Debt-to-Equity (D/E) ratio 0.32, conservative). Current ratio is 2.95 (strong liquidity). Debt-to-assets is 20.5%. Total assets: $230M.

Analyst outlook: 4 / 6 analysts rate THRN as buy (67%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 23/100 (Fail), Growth 100/100 (Pass), Past 50/100 (Partial), Health 100/100 (Pass), Moat 64/100 (Partial), Future 37/100 (Fail), Income 45/100 (Partial).

$5.75
▼ 43.57% Downside
Average Price Target
Based on 6 Wall Street analysts offering 12-month price targets for Thorne HealthTech, Inc., the average price target is $5.75, with a high forecast of $6.00, and a low forecast of $5.50.
Highest Price Target
$6.00
Average Price Target
$5.75
Lowest Price Target
$5.50

THRN SharesGrow Score Overview

60/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 23/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 64/100
Gross margin is + market cap
FUTURE 37/100
Analyst outlook — as buy
INCOME 45/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — THRN

✗
VALUE Fail
23/100
THRN trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $6, implying -41.1% from the current price $10. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✓
GROWTH Pass
100/100
THRN: +30.8%/yr revenue is, +221.5%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
THRN: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
100/100
Balance sheet THRN: Debt-to-Equity (D/E) ratio 0.32 (conservative), Current ratio is 2.95 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
64/100
THRN: Gross margin is 50.2% (+6.6 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 64/100. ≥ 70 = Pass.
View details →
✗
FUTURE Fail
37/100
Analyst outlook: 4 / 6 analysts rate THRN as buy (67%). Analyst consensus target is $6 (-41.1% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
45/100
THRN: Net profit margin is 6.9%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range3.41-10.2
Volume84.69K
Avg Volume (30D)244.81K
Market Cap$550.63M
Beta (1Y)0.82
Share Statistics
EPS (TTM)0.30
Shares Outstanding$52.76M
IPO Date2021-09-23
Employees544
CEOPaul F. Jacobson
Financial Highlights & Ratios
Revenue (TTM)$228.73M
Gross Profit$114.93M
EBITDA$10.31M
Net Income$15.67M
Operating Income$5.48M
Total Cash$36.02M
Total Debt$47.03M
Net Debt$11.01M
Total Assets$229.8M
Price / Earnings (P/E)34
Price / Sales (P/S)2.41
Analyst Forecast
1Y Price Target$5.75
Target High$6.00
Target Low$5.50
Upside-43.6%
Rating ConsensusBuy
Analysts Covering6
Buy 67% Hold 33% Sell 0%
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS8852601090

Price Chart

Track all markets on TradingView
THRN
Thorne HealthTech, Inc. ↗  ·  NASDAQ Global Select
Consumer Defensive • Packaged Foods
3.41 52WK RANGE 10.20

People Also View

ASBFF
ASBFF
Associated British Foods plc
$23.18
-17.07%
 POST
POST
Post Holdings, Inc.
$100.59
+0.73%
 LANC
LANC
Lancaster Colony Corporation
$172.77
-4.03%
 CENT
CENT
Central Garden & Pet Company
$36.90
-3.15%
 CENTA
CENTA
Central Garden & Pet Company
$33.56
-0.53%
 BRBR
BRBR
BellRing Brands, Inc.
$15.47
+2.38%
 JJSF
JJSF
J&J Snack Foods Corp.
$81.70
-0.62%
 NOMD
NOMD
Nomad Foods Limited
$9.52
-1.55%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message